KeyCorp Upgrades Sherwin-Williams (NYSE:SHW) to Hold

Sherwin-Williams (NYSE:SHW) was upgraded by stock analysts at KeyCorp to a “hold” rating in a report issued on Thursday, Zacks reports. KeyCorp also issued estimates for Sherwin-Williams’ Q3 2026 earnings at $3.63 EPS, Q4 2026 earnings at $2.43 EPS, FY2027 earnings at $13.25 EPS and FY2028 earnings at $15.20 EPS.

A number of other analysts have also commented on SHW. DA Davidson set a $400.00 price objective on Sherwin-Williams and gave the company a “buy” rating in a research note on Monday, August 24th. Jefferies Financial Group reissued a “hold” rating and issued a $375.00 target price on shares of Sherwin-Williams in a research note on Tuesday, July 28th. Guggenheim initiated coverage on shares of Sherwin-Williams in a report on Monday, August 3rd. They issued a “buy” rating and a $400.00 target price on the stock. Weiss Ratings raised shares of Sherwin-Williams from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, August 26th. Finally, Citigroup reiterated a “buy” rating on shares of Sherwin-Williams in a report on Wednesday, July 29th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $386.29.

Sherwin-Williams Price Performance

SHW stock opened at $317.42 on Thursday. Sherwin-Williams has a 1 year low of $289.86 and a 1 year high of $377.77. The company has a debt-to-equity ratio of 2.16, a quick ratio of 0.46 and a current ratio of 0.73. The stock’s 50 day moving average price is $341.31 and its 200 day moving average price is $329.80. The firm has a market cap of $77.06 billion, a P/E ratio of 29.25, a PEG ratio of 2.39 and a beta of 1.09.

Sherwin-Williams (NYSE:SHW) last announced its earnings results on Tuesday, July 28th. The specialty chemicals company reported $3.70 EPS for the quarter, beating analysts’ consensus estimates of $3.52 by $0.18. The firm had revenue of $6.79 billion for the quarter, compared to analysts’ expectations of $6.60 billion. Sherwin-Williams had a return on equity of 67.97% and a net margin of 11.01%.Sherwin-Williams’s quarterly revenue was up 7.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $3.38 EPS. Sherwin-Williams has set its FY 2026 guidance at 11.800-12.200 EPS. On average, sell-side analysts expect that Sherwin-Williams will post 12.08 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Karl J. Jorgenrud sold 7,886 shares of the company’s stock in a transaction dated Friday, August 7th. The shares were sold at an average price of $368.30, for a total transaction of $2,904,413.80. Following the completion of the transaction, the insider owned 11,944 shares of the company’s stock, valued at $4,398,975.20. This represents a 39.77% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Justin Binns sold 13,500 shares of the stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $352.70, for a total transaction of $4,761,450.00. Following the transaction, the insider owned 21,937 shares in the company, valued at approximately $7,737,179.90. The trade was a 38.10% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Corporate insiders own 0.23% of the company’s stock.

Hedge Funds Weigh In On Sherwin-Williams

Several institutional investors and hedge funds have recently bought and sold shares of SHW. Sapient Capital LLC grew its stake in shares of Sherwin-Williams by 0.3% in the 4th quarter. Sapient Capital LLC now owns 9,176 shares of the specialty chemicals company’s stock worth $2,993,000 after acquiring an additional 30 shares in the last quarter. Eastern Bank lifted its position in shares of Sherwin-Williams by 50.8% during the second quarter. Eastern Bank now owns 89 shares of the specialty chemicals company’s stock valued at $31,000 after purchasing an additional 30 shares in the last quarter. Deseret Mutual Benefit Administrators boosted its holdings in Sherwin-Williams by 6.2% during the fourth quarter. Deseret Mutual Benefit Administrators now owns 527 shares of the specialty chemicals company’s stock worth $171,000 after purchasing an additional 31 shares during the last quarter. Heartland Bank & Trust Co grew its position in Sherwin-Williams by 2.8% in the 1st quarter. Heartland Bank & Trust Co now owns 1,174 shares of the specialty chemicals company’s stock worth $376,000 after purchasing an additional 32 shares in the last quarter. Finally, Physician Wealth Advisors Inc. grew its position in Sherwin-Williams by 8.5% in the 1st quarter. Physician Wealth Advisors Inc. now owns 432 shares of the specialty chemicals company’s stock worth $138,000 after purchasing an additional 34 shares in the last quarter. Institutional investors and hedge funds own 77.67% of the company’s stock.

About Sherwin-Williams

The Sherwin-Williams Company (NYSE: SHW) develops, manufactures, distributes and sells paints, coatings, floorcoverings and related products. Its offerings serve professional contractors, industrial and commercial customers, retailers and do-it-yourself consumers, with products used in residential, commercial, industrial and infrastructure applications.

The company operates through three primary business segments: Paint Stores Group, which supplies professional painting contractors through company-operated stores; Consumer Brands Group, which markets products through home-improvement retailers and other channels; and Performance Coatings Group, which provides specialized coatings for industrial, automotive, aerospace, packaging and other markets.